$GILD New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardless of Initial HR/HER2 Status

on September 16, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT Study

on September 16, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead to Present New Data at ESMO Congress 2021 Reinforcing the Practice-changing Potential of Trodelvy

on September 13, 2021 News and Tags: , , , with 0 comments
Time:
8:30 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences to Present at Upcoming Investor Conference

on September 1, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Human Rights Campaign and Gilead Will Work Together to Combat HIV Epidemic and Promote Transgender Justice

on August 24, 2021 News and Tags: , , , with 0 comments
Time:
9:15 AM
Symbol:
GILD
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$GILD Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021

on May 19, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences to Present at Upcoming Investor Conferences

on May 14, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more